StonvexLoading…
StonvexStonvexStonvexCore line items from CPHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $13.51M | $59.57M | $47.12M | $28.81M |
Operating Income | $1.06M | $2.46M | $2.13M | $1.08M |
Net Income | $169.88K | $-529.43K | $-139.33K | $-626.62K |
EPS (Diluted) | $0.03 | $-0.10 | $-0.03 | $-0.12 |
Total Assets | $113.52M | $112.58M | $114.38M | $114.93M |
Total Liabilities | $29.51M | $28.70M | $30.26M | $31.33M |
Cash & Equivalents | $12.19M | $12.06M | $11.96M | $12.44M |
Free Cash Flow OCF − CapEx | $2.61M | $4.72M | $5.33M | $5.72M |
Shares Outstanding | 5.15M | 5.12M | 5.10M | 5.09M |